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Research
nternational and Australian stud-
ies show that well structured
approaches to diabetes care can
improve short-term and intermediate
patient outcomes.1,2 While there are
several long-term randomised con-
trolled trials aimed at improving inter-
mediate outcomes in people with
diabetes,3,4 there is only one pub-
lished study on the long-term evalua-
t ion of  a  cont inuous  qual i ty
improvement (CQI) program in real-
world settings of primary health care.5
Ten years after this CQI program was
introduced, there was significant
improvement in intermediate out-
comes and a reduction in microvascu-
lar and macrovascular disease in
patients with diabetes in Catalonia.5
In Australia, only limited, generally
short-term, studies have been pub-
lished on the effectiveness of real-life
service approaches to improving dia-
betes control. One showed significant
improvement in some intermediate
outcomes for patients with diabetes in
Far North Queensland following the
introduction of the “Meriba Zageth
for diabetes” plan.6
Derby is a small remote Western
Australian town with a harsh seasonal
climate, 230 km from the regional
centre of Broome and 2350 km from
Perth tertiary referral centres. The
2006 census rated the Derby–West
Kimberley area as the fifth most dis-
advantaged in Western Australia.7
Recruitment and retention of skilled
professionals in Derby is a constant
challenge, with a number of key local
services characterised by high staff
turnover. Derby Aboriginal Health
Service (DAHS) is an Aboriginal com-
munity-controlled health service that
was established in 1998. Key charac-
teristics of DAHS include whole-of-
service involvement in internal CQI
processes, use of electronic patient
information and recall systems, and
regional support and standardisation
of care.
We aimed to report on long-term
service activity and intermediate clini-
cal outcomes for DAHS Aboriginal
and Torres Strait Islander patients
with type 2 diabetes.
Methods
This study covers 10 audit years, from
1 July 1999 to 30 June 2009. It includes
Aboriginal and Torres Strait Islander
patients seen at DAHS who had type
2 diabetes mellitus, were  15 years
old, received primary care from DAHS
for at least 6 continuous months, lived
in or near Derby, and were not on
renal replacement therapy.
The final study population was
determined by carrying out a compre-
hensive retrospective review of paper
and electronic records. During review
of these records, the date of diagnosis
of diabetes for each patient was con-
firmed as far as possible.
Data extraction and cleaning
In 2007, DAHS staff checked the
accuracy of patients’ electronic
records against paper records. Results
incorrectly recorded or not entered
into Project Ferret (Pen Computer
Systems), a patient information and
recall system, were corrected. From
2007, data entry was monitored more
closely. At the end of 2009, data were
extracted from Project Ferret and
transferred into Excel 2003 (Micro-
soft). Outliers were identified and
data entry errors were corrected.
Fewer electronic creatinine results
than expected were observed during
the audit years 2005–06 and 2006–07
and further corrections, based on
paper records, were made. The data
were then imported into Stata, ver-
sion 11 (StataCorp).
Service characteristics
The major activities and factors likely
to have had a direct impact on the
quality of care provided to patients
with diabetes at DAHS are listed in
Box 1.
Quality indicators of diabetes care
The occurrence of activities relating to
diabetes management was assessed
over the 10 audit years. Measures
Quality indicators of diabetes care: 
an example of remote-area Aboriginal 
primary health care over 10 years
I Objectives:  To describe service characteristics of Derby Aboriginal Health Service (DAHS) and document diabetes management activities and intermediate clinical 
outcomes for Aboriginal patients with type 2 diabetes.
Design, setting and patients: Retrospective audit of records for patients  15 
years old who had a confirmed diagnosis of type 2 diabetes, received primary 
health care from DAHS for at least 6 continuous months between 1 July 1999 and 
30 June 2009, resided in the Derby area and were not on renal replacement 
therapy.
Main outcome measures: Electronic records of blood pressure (BP), glycated 
haemoglobin (HbA1c) level, weight, albumin–creatinine ratio, creatinine level or 
estimated glomerular filtration rate, lipid levels and smoking status during each 
audit year; and proportions of patients who met clinical targets for HbA1c, BP 
and cholesterol.
Results: Over the 10 years, the proportion of clinical care activities undertaken 
according to regional protocols increased significantly, with very high levels 
recorded in the last 3 years (at least 70% of patients had each activity recorded). 
There were significant improvements in systolic BP, diastolic BP and cholesterol 
levels over the 10 years (P< 0.001 for all). In the final year, 69% of patients had at 
least half their BP measurements  130/80 mmHg and 83% had median annual 
cholesterol levels of < 5.5 mmol/L. There were small improvements in HbA1c 
levels that approached statistical significance (P= 0.05). In the final year, 34% 
of patients had median annual HbA1c levels of  7.0%.
Conclusions: This study shows that diabetes monitoring and outcomes can be 
improved and maintained over a 10-year period in a well supported remote 
Aboriginal community-controlled health service setting.
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expected to be recorded at least 6
monthly (blood pressure [BP], gly-
cated haemoglobin [HbA1c] level,
weight) were assessed over the last 6
months of each audit year (1 January
to 30 June). Measures expected to be
recorded annually (albumin–creati-
nine ratio [ACR], creatinine level or
estimated glomerular filtration rate
[eGFR], lipid levels, smoking status)
were assessed over the full audit year.
Clinical outcome measures
Clinical outcome measures were
assessed each audit year. Overall
median HbA1c and cholesterol levels
were determined using medians for
individual patients during each audit
year. Also, the proportions of
patients with median HbA1c and
cholesterol levels meeting recom-
mended targets11 were determined
for each audit year. As the recom-
mended target for BP includes meet-
ing the target for both systolic
(  1 3 0 m m H g )  a n d  d i a s t o l i c
( 80 mmHg) measurements, the
proportions of patients with at least
half their electronic measurements
meeting both targets were deter-
mined for each audit year.
Patients were classified as having
proteinuria and/or kidney disease if
they had at least two ACR results
> 3.6 mg/mmol without obvious infec-
tion, creatinine or eGFR results sug-
gestive of chronic kidney disease,10
and/or were assigned to a proteinuria
or chronic kidney disease care plan.
Statistical analysis
A non-parametric test for trend across
ordered groups was used to assess
trend over time.12 Analyses were per-
formed using Stata, version 12 (Stata-
Corp). P < 0.05 was considered
statistically significant.
Ethics approval
Ethics approval was obtained from the
Western Australian Aboriginal Health
Information and Ethics Committee
and exemption from ethics review was
obtained from the Human Research
Ethics Committee of the University of
Western Australia.
Results
After identifying 517 patients with
results suggestive of diabetes, 263
were excluded for not meeting the
selection criteria (Box 2). Participants
who commenced renal replacement
therapy, stopped receiving primary
care from DAHS or died were not
included after these events occurred.
The final study population of 254
patients contributed a total of 1502
patient-years of care. Of this patient
population, 107 (42%) were diag-
nosed after becoming a regular
patient at DAHS, 195 (77%) regularly
attended DAHS (as determined by the
clinic) from when they entered the
study until they were excluded or the
study finished, 166 (65%) were
included in at least 5 audit years, 35
(14%) were included in all 10 years
and 45 (18%) were included in both
the first and last years. The median
age of patients at the time of entering
the study was 46 years (range, 15–84
years); 159 patients (63%) were
female, 185 (73%) had or developed
proteinuria and/or kidney disease, 12
(5%) commenced renal replacement
therapy and 41 (16%) died.
Service activity for BP, HbA1c,
weight, ACR, creatinine level or
eGFR, lipid levels and smoking status
increased significantly over time
(P  0.002 for trend over 10 years; Box
3). Median annual systolic and dia-
stolic BP values and cholesterol levels
decreased significantly over time
(P0.001 for trend over 10 years; Box 4).
The proportion of patients who met
currently recommended targets11 for
median annual cholesterol and who
had at least half their recorded results
for BP  130/80 mmHg also signifi-
cantly increased over time (P  0.001
for trend over 10 years; Box 4).
Improvements in glycaemic control
over time approached statistical sig-
nificance (P = 0.05 for trend over 10
years; Box 4). In the last year of the
study, the proportions of patients who
met the old targets of HbA1c < 7.0%
and BP < 130/80 mmHg were 33%
and 53%, respectively. Previously
reported data on care quality indica-
tors and clinical outcome measures
relating to diabetes care in other Aus-
tralian populations are included in
Box 3 and Box 4, respectively.1,6,8,9,13-19
1 Major activities and factors likely to have directly affected quality of care 
provided by DAHS to patients with diabetes, 1999–2009
• Aboriginal community-controlled health service, with stable governance by 
community-elected board of directors and executive managers
• After operating in the early stages on a limited start-up budget, DAHS secured a 
purpose-built facility in 2005 and has drawn incrementally increasing resources to 
support service growth and diversification in response to demand
• Electronic health information systems:
 in addition to paper records, a patient information and recall system (Project 
Ferret) was used to capture key clinical data; it was also used for reporting and 
CQI purposes
 data entry clerk changed infrequently, ensuring consistency over time
• Significant consistency of senior staff
• Specialist outreach services, including visiting general physicians, dietitians, 
podiatrists and diabetes educators
• Formal and informal teaching and upskilling incorporated into routine practice:
 medical students hosted for their penultimate year, general practice registrar 
training, junior doctor placements, Aboriginal health worker student placements 
and nursing student placements
• CQI approaches based on a culture of organisational appraisal and improvement, 
encouraging review and reflection by staff at all levels, and embracing change in 
response to identified gaps
• Formalised CQI processes included:
 brief participation in the Australian Primary Care Collaboratives program8 and 
the Audit and Best Practice for Chronic Disease project9
 ongoing internal and external (Kimberley Aboriginal Medical Services Council) 
audit of service data
 formalisation of regular audit process during the 2006–07 audit year, by 
introducing an internally developed standardised audit tool and routine audit 
process
• Regional support and standardisation of systems:
 part of a regional collective of Aboriginal community-controlled health services
 development and implementation across health sectors of the Kimberley 
Standard Drug List and evidence-based Kimberley Chronic Disease Therapeutic 
Protocols10
DAHS = Derby Aboriginal Health Service. CQI = continuous quality improvement. ◆
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Discussion
To our knowledge, this is the first
published Australian study looking at
10 years of diabetes management in
primary care at an individual health
service. We showed significant and
sustained improvements in health
monitoring and intermediate out-
comes at DAHS.
Improved care processes, improved
control of BP and prevention of com-
plications that result in hospitalisation
have previously been demonstrated in
Aboriginal community-controlled
health services over short periods
when adequate clinical support and
appropriate management structures
have been provided.2,13
The main strength of our study is
that we used all recorded results for
patients over a 10-year period and
analysed clinical outcomes according
to clinical targets from current guide-
lines.11 Comparisons can be made
with other studies, but caution is
required because of the different
methods and clinical targets used. The
Australian Primary Care Collabora-
tives program operates through
“waves” of 20–200 practices working
together over 18 months,8 while the
Audit and Best Practice for Chronic
Disease project randomly selected 30
patients with diabetes from each of 62
services and used the most recent
value for each patient within 12
months of the audit.9 The currently
recommended target for BP is  130/
80 mmHg,11 but previously it was
< 130/80 mmHg. In our study, this
meant that the proportion of patients
with BP complying with target values
changed from 53% to 69% in the final
year. Similar changes occurred in the
Australian National Diabetes Audit
and Benchmarking project (54% of
patients with BP  130/80 mmHg in
2009 compared with 38% of patients
with BP < 130/80 mmHg in 2006).17,20
The change in HbA1c target (< 7.0%
to  7.0%) made less difference in our
study (33% v 34% of patients meeting
the respective targets in the final
year).
Limitations of this study included
underrecording. In the earlier years,
this may have contributed to the
trend of improvements over time. As
part of the CQI processes at DAHS,
staff checked the accuracy of the
measures reported in this article and
updated electronic records, but some
bias due to underrecording in the
earlier years is likely. Our data on the
duration of diabetes may also be
biased because of difficulties in deter-
mining when diabetes was diagnosed
in patients who were diagnosed at
other health services. This study was
also limited to data that were availa-
ble; important outcomes, such as hos-
pital admissions and medication
usage, were not recorded electroni-
cally and more sophisticated meas-
ures relating to quality of life were not
collected.
Our results compare well with
those of other Australian studies of
patients with diabetes. In terms of the
intermediate outcome measures that
we examined, BP was better control-
led than in other Australian studies,
including mainstream general prac-
tice studies (69% v 28%–54%8,16,17),
and cholesterol levels were similar or
better (83% v 53%–86%9,15-19). Gly-
caemic control was near the best
reported in Indigenous Australian
studies (34% v 22%–32%1,6,9,14,15) but
not as good as has been reported in
studies of mainstream general prac-
tice (37%–57%).8,18,19
Despite the improvements we have
shown, there is substantial room for
further improvements in clinical out-
comes. The focus on preventing or
delaying kidney failure in the Kimber-
ley may partly explain why BP control
was particularly good in this study.
Glycaemic control is considered more
difficult to achieve compared with
other measures6 and only small
improvements in glycaemic control
were evident in this study, although
even small improvements can be clini-
cally useful. Further investigation is
planned to model HbA1c measure-
ments over time for individuals and
determine factors that are likely to
2 Selection process used to determine DAHS study population
DAHS = Derby Aboriginal Health Service. RRT = renal replacement therapy. ◆
517 patients  15 years old who had attended DAHS 
from 1 July 1999 to 30 June 2009 were identified as 
having results suggestive of diabetes, indicated by one 
or more of the following
• on a diabetes care plan
• diagnosis of diabetes on paper records
• taking hypoglycaemic medication
• fasting plasma glucose level  7.0 mmol/L
• random plasma glucose level  11.1 mmol/L
100 patients did not have confirmed type 2 diabetes
• 31 did not have diabetes
• 67 had only one abnormal test result relating to diabetes and had 
   not been formally diagnosed
• 2 had type 1 diabetes
417 patients had confirmed type 2 diabetes
143 patients did not receive regular care
• 78 received primary care elsewhere
• 57 were visitors and not Derby area residents
• 8 received < 6 months care from DAHS after being diagnosed 
   with diabetes
20 patients were excluded from the study for other reasons
• 17 were not Indigenous Australians
• 3 commenced RRT before being diagnosed with diabetes
274 patients had confirmed type 2 diabetes and were 
regular DAHS patients
254 patients were included in the study
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contribute to individuals attaining and
maintaining good glycaemic control.
From 2012, reporting of national
key performance indicators (nKPIs) is
a requirement for Aboriginal commu-
nity-controlled health services under
the National Indigenous Reform
Agreement.21 The nKPIs include the
HbA1c and BP measures for patients
with diabetes that we included in our
study. It is hoped that the use of
nKPIs will result in comparable data
from Aboriginal health services being
produced.
Over the decade covered by our
study, a number of policy changes
were introduced at a national level
which may have had an enabling
role for DAHS in chronic disease
care for its patients. These include
the introduction of Medicare reim-
bursement for comprehensive Abo-
riginal and Torres Strait Islander
preventive health checks and for
chronic disease management plan-
ning and follow-up,22 and access to
medications at low or no cost for
Aboriginal people in remote areas
(section 100 of the National Health
Act 1953 [Cwlth]).23
DAHS had regular changes in
health staff and management, but it
also had significant consistency in
senior staff over the decade we stud-
ied. The service also had improving
resources over the study period,
although resourcing started from a
low base. DAHS maintained its com-
munity connections with a consistent
board of directors, long-term employ-
ment of Aboriginal health workers
and nurses, and a focus on genuine
comprehensive primary health care
for its patients.
Sustainability of chronic disease
programs has previously been
reported to be a major challenge in
remote Aboriginal and Torres Strait
Islander health settings.24 This study
shows that diabetes monitoring and
outcomes can be improved and main-
tained over a 10-year period in a
remote Aboriginal community-con-
trolled health service setting.
4 Clinical outcome measures of DAHS study population and proportions of those with outcome values that met currently recommended targets during 
the 10 audit years, and corresponding values from the final years of other studies
 
Audit year
P*
Indigenous 
Australians, 
PHC†
Australians, 
secondary‡
Australians, 
PHC§
1999
–00
2000
–01
2001
–02
2002
–03
2003
–04
2004
–05
2005
–06
2006
–07
2007
–08
2008
–09
Median annual clinical outcome measures
Systolic BP (mmHg) 135 134 130 128 124 120 120 120 120 120 < 0.001 128–130 130 134
Diastolic BP (mmHg) 85 80 81 80 80 80 78 75 74 75 < 0.001 78–80 75 78
HbA1c (%, mmol/mol) 8.2, 66 8.7, 72 8.2, 66 7.7, 61 8.1, 65 8.3, 67 8.1, 65 8.0, 64 7.6, 60 8.0, 64 0.05 8.1–9.0 7.9 6.8–7.4
Cholesterol (mmol/L) 5.0 5.0 5.1 4.9 5.0 4.9 4.6 4.7 4.6 4.5 < 0.001 4.7–5.0 4.3 4.7
Proportion of study population with median values that met targets
BP  130/80 mmHg¶ 38% 46% 44% 53% 66% 66% 67% 75% 70% 69% < 0.001 28%–54% 34%
HbA1c  7.0% ( 53 mmol/mol) 26% 28% 34% 34% 31% 24% 32% 36% 39% 34% 0.05 22%–32% 30%–32% 37%–57%
Cholesterol < 4.0 mmol/L** 4% 12% 8% 22% 16% 18% 16% 21% 24% 25% < 0.001 29% 22%
Cholesterol < 5.5 mmol/L†† 64% 63% 71% 76% 73% 72% 76% 75% 81% 83% < 0.001 65%–79% 80%–86% 53%–85%
DAHS = Derby Aboriginal Health Service. PHC = primary health care. BP = blood pressure. HbA1c = glycated haemoglobin. * For trend over 10 years. † Australian Aboriginal and 
Torres Strait Islander patients treated in PHC settings.1,6,9,14,15 ‡ General Australian population treated in secondary care settings.16,17 § General Australian population treated in 
mainstream general practice settings.8,18,19 ¶ At least half of each participant’s recorded measurements met the recommended target for both systolic and diastolic BP. 
** Recommended for people with diabetes.11 †† Recommended for the general population. ◆
3 Proportions of DAHS study population for whom diabetes management activities were recorded in the electronic patient and information recall 
system during the 10 audit years, and corresponding values from the final years of other studies
Audit year
Indigenous 
Australians, 
PHC†
1999
–00
2000
–01
2001
–02
2002
–03
2003
–04
2004
–05
2005
–06
2006
–07
2007
–08
2008
–09 P*
Total no. of patients‡ 582 816 603 699 808 982 943 1232 1349 1227
No. of patients included in study 80 129 136 136 164 176 172 172 177 173
Median time since diagnosis, at 30 June (years) 1.3 2.2 3.0 4.0 4.4 5.4 6.0 6.8 7.5 8.5
Proportion of patients for whom activity was recorded
Blood pressure§ 74% 77% 64% 71% 75% 74% 74% 81% 82% 80% 0.002 65%–83%
HbA1c
§ 53% 60% 68% 66% 69% 66% 72% 75% 70% 74% < 0.001 56%–73%
Weight§ 53% 58% 49% 45% 64% 61% 65% 75% 79% 74% < 0.001 51%–74%
Albumin–creatinine ratio¶ 45% 47% 51% 54% 77% 67% 65% 77% 79% 81% < 0.001 50%–83%
Creatinine level or eGFR¶ 68% 74% 72% 85% 83% 80% 75% 87% 87% 94% < 0.001 69%–86%
Lipid levels¶ 56% 62% 53% 67% 72% 68% 70% 80% 79% 91% < 0.001 52%–88%
Smoking status¶ 11% 45% 14% 48% 60% 49% 38% 70% 80% 85% < 0.001 24%
All seven activities 0 19% 6% 14% 29% 22% 18% 47% 47% 50% < 0.001
Mean no. of activities recorded 2.9 4.2 3.6 4.1 4.9 4.3 4.3 5.3 5.4 5.5 < 0.001
DAHS = Derby Aboriginal Health Service. PHC = primary health care. HbA1c = glycated haemoglobin. eGFR = estimated glomerular ﬁltration rate. * For trend over 10 years. † Australian 
Aboriginal and Torres Strait Islander patients treated in PHC settings.1,9,13,14 ‡ All DAHS patients 15 years of age who had at least one electronic blood pressure or weight measurement 
recorded. § Process recorded from 1 January to 30 June during each audit year. ¶ Process recorded from 1 July to 30 June during each audit year. ◆
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